Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination

Heart Lung Circ. 2021 Oct;30(10):1425-1429. doi: 10.1016/j.hlc.2021.07.011. Epub 2021 Jul 31.
No abstract available

Keywords: ANZSCTS; Australia; COVID-19; CSANZ; Cardiomyopathy; Cardiovascular disease; Myocarditis; Pericarditis; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); mRNA vaccine.

Publication types

  • Editorial

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Cardiomyopathies* / diagnosis
  • Cardiomyopathies* / etiology
  • Humans
  • Myocarditis* / diagnosis
  • Myocarditis* / etiology
  • Pericarditis* / diagnosis
  • Pericarditis* / etiology
  • SARS-CoV-2
  • Vaccination / adverse effects

Substances

  • COVID-19 Vaccines